Press Releases
Cowden Syndrome Market Brief Analysis By Top Key Players

Cowden Syndrome Market

, 17 April 2019 -- Cowden Syndrome Market is driven by Innovation in technology, increasing investments in the R&D sectors, strong support from the governmental bodies to develop new treatments, rising expenditures on healthcare, availability of latest technology, supportive governmental rules and regulation and rising awareness.

Cowden syndrome is form of genetically inherited disease which can be characterized by the formation of numerous hamartomas, which are noncancerous growths, resembling the structure of tumors. However, the occurrence of this syndrome increases the risks of developing several types of cancers like breast cancers, thyroid cancer, and uterus cancer among others. The occurrence of hamartomas is mostly found under the mucosal membrane of the skin or nose and also in body parts like the intestines. Studies conducted have associated occurrence of Cowden syndrome and Cowden-like syndrome among the population with the involvement of 4 distinct genes, i.e. the PTEN, SDHB, SDHD, and KLLN. However, most cases of Cowden syndrome can be attributed to the mutation of the PTEN gene, as this gene is involved in production of protein which functions as a tumor-suppressor. The prevalence rate of Cowden syndrome is unknown, and is estimated that 1 in every 200,000 individual gets affected by this syndrome. The presence of such low patient pool has been a major hindrance in the growth of the cowden syndrome market, as it has directly affected the number of individuals under the study for formulation of new treatments and drugs. Similarly, favorable reimbursement policies by the governmental bodies have played a crucial role in supporting the growth of the cowden syndrome market. Moreover, lack of treatment has led to governments of various nations to initiate new studies and research to develop new medications, procedures and other cures for such conditions.

Read Report Overview:

The global cowden syndrome market can be segmented based of site, and treatment. On basis of site the cowden syndrome market can be further classified into colorectal, thyroid, skin (melanoma), breast, endometrium (uterus), kidney, and others. Whereas, on the basis of treatment the cowden syndrome market can be classified into chemotherapy, hormone therapy, genetic testing, surgery & radiation therapy, biologic therapy, targeted therapy and others. The segment of chemotherapy can further be classified into antimetabolites, anthracyclines, alkylating agents and taxanes. Similarly, the targeted therapy segment can be further sub-segmented into tyrosine kinase inhibitors and monoclonal antibodies. The Hormone therapy segment is segmented into aromatase inhibitors, Selective estrogen-receptor modulators (SERMs) and others.

Geographically, the global cowden syndrome market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for major share of the global cowden syndrome market in terms of revenue in 2018, followed by Europe.

Innovation in technology, increasing investments in the R&D sectors, strong support from the governmental bodies to develop new treatments, rising expenditures on healthcare have played a pivotal role in developing the Cowden syndrome market in North American region. Europe is estimated to be the second largest Cowden syndrome market, followed by Asia Pacific and Latin America. The availability of latest technology, supportive governmental rules and regulation, rising awareness can be considered as few factors which have positively contributed to the growth of the market, in these region. The rapid growth of the nations with developing economies have also presented a bright prospect of growth for the Asia Pacific region, which is expected to witness unhindered growth during the forecast period. Whereas, regions like the Middle East Africa and Latin America will also observe significant growth during the forecast period, owing to rising expenditures on healthcare facilities and growing awareness among the population.

Obtain the Report Brochure:

The major players in the global Cowden syndrome market are Sanofi, Takeda Pharmaceuticals, Merck & Co., Inc. Immunomedics Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Global Services, LLC, GlaxoSmithKline plc. Spectrum Pharmaceuticals, Inc., Novartis AG. and others.

About Us:

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.


Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

# # #

Submitted by hawer on Wednesday, 17 April 2019 at 9:50 PM
Category: Health Care & Medical
Related News

Coronary Stents Market: Increase in Geriatric Population to Drive Demand
Friday, 19 Apr 2019

Wearable Medical Devices Market - Rising Number of Sports and Fitness Enthusiasts to Boost the Deman
Friday, 19 Apr 2019

Catheters Market - Increasing Demand for Minimally Invasive Surgeries to Spur the Demand
Friday, 19 Apr 2019

Fragment-based Drug Discovery Market Will be Worth US$1.15 bn by 2023
Friday, 19 Apr 2019

Homeopathy Product Market is Projected to be Worth US$17,486.2 mn by 2024
Friday, 19 Apr 2019

Related Events

3rd Annual NASH Summit | April 22-25, 2019 | Boston, MA
Monday, 22 Apr 2019

Rx Drug Abuse and Heroin Summit
Monday, 22 Apr 2019

European NeoAg Summit 2019
Tuesday, 23 Apr 2019

Wednesday, 24 Apr 2019

8th Digital Marketing for Medical Devices West
Wednesday, 24 Apr 2019

Latest News

Four Years of Despair Book Launch
Sunday, 21 Apr 2019

Sunday, 21 Apr 2019

Infographic presenting the 6 Steps to Sell a House in Wisconsin
Sunday, 21 Apr 2019

Benefits of the Amazing Red Tea for Weight Loss in the Healthiest Way
Sunday, 21 Apr 2019

Caviar Benefits for your Health
Sunday, 21 Apr 2019

Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Sunday, 21 April 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Consumer Technology
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
News & Media
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!

Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.

  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.

  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Palo Alto Networks: Palo Alto Networks Next Generation Firewall Hands-on Seminar
  • DOZ Live Inspirational Conference (DOZ Live)
  • 3rd Annual NASH Summit | April 22-25, 2019 | Boston, MA
  • Rx Drug Abuse and Heroin Summit
  • European NeoAg Summit 2019

  • Latest Jobs
    Sorry, there are currently no entries posted here.